Ginkgo Bioworks (DNA) Misses Q3 EPS by 5c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $77.6 million versus the consensus estimate of $45.75 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
• Pfizer reaffirms 2026 guidance after CFO transition news